Qinlock 50 mg
Qinlock 50 mg is a medicine authorised by Swissmedic under authorisation number 68199. The authorisation holder is Deciphera Pharmaceuticals (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 07 October 2021 and the authorisation is valid without a time limit. ATC code L01EX19 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68199 |
|---|---|
| Name | Qinlock 50 mg |
| Full name | Qinlock 50 mg, Tabletten |
| Authorisation holder | Deciphera Pharmaceuticals (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EX19 |
| First authorisation | 07 October 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Qinlock 50 mg, Tabletten | A | 07 October 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 90 | Tablette(n) | L01EX19 | 07.16.1. | A |
Scroll the table sideways
Frequently asked questions
Is Qinlock 50 mg authorised in Switzerland?
Yes. Qinlock 50 mg is authorised by Swissmedic under authorisation number 68199, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Qinlock 50 mg have?
Qinlock 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Qinlock 50 mg?
The authorisation holder is Deciphera Pharmaceuticals (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.